These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 25776438)

  • 41. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
    Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
    Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementing Intensity-modulated Radiotherapy with Simultaneous Integrated Boost for Anal Cancer: 3 Year Outcomes at Two Sydney Institutions.
    Yates A; Carroll S; Kneebone A; Tse R; Horvath L; Byrne C; Solomon M; Hruby G
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):700-7. PubMed ID: 26382849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
    J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey.
    Esin E; Yıldız F; Laçin Ş; Karakaş Y; Gültekin M; Dizdar Ö; Yalçın Ş
    Turk J Gastroenterol; 2018 Jul; 29(4):411-418. PubMed ID: 30249555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
    Roohipour R; Patil S; Goodman KA; Minsky BD; Wong WD; Guillem JG; Paty PB; Weiser MR; Neuman HB; Shia J; Schrag D; Temple LK
    Dis Colon Rectum; 2008 Feb; 51(2):147-53. PubMed ID: 18180997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
    Klas JV; Rothenberger DA; Wong WD; Madoff RD
    Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.
    Longo WE; Vernava AM; Wade TP; Coplin MA; Virgo KS; Johnson FE
    Ann Surg; 1994 Jul; 220(1):40-9. PubMed ID: 8024357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.
    Banerjee R; Roxin G; Eliasziw M; Joseph K; Maclean A; Buie WD; Doll C
    Dis Colon Rectum; 2013 Sep; 56(9):1036-42. PubMed ID: 23929012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).
    Matzinger O; Roelofsen F; Mineur L; Koswig S; Van Der Steen-Banasik EM; Van Houtte P; Haustermans K; Radosevic-Jelic L; Mueller RP; Maingon P; Collette L; Bosset JF;
    Eur J Cancer; 2009 Nov; 45(16):2782-91. PubMed ID: 19643599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal].
    Peiffert D
    Cancer Radiother; 2003 Nov; 7 Suppl 1():100s-107s. PubMed ID: 15124551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.
    Evesque L; Benezery K; Follana P; Tuan Falk A; Doyen J; Reure J; Cavaglione G; François E
    Dis Colon Rectum; 2017 Aug; 60(8):785-791. PubMed ID: 28682963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal Cancer.
    Leiker AJ; Wang CJ; Sanford NN; Aguilera TA; Karri S; Beg MS; Kazmi SA; Olson C; Matthews JA; Abdelnaby A; Meyer JJ; Folkert MR
    Am J Clin Oncol; 2020 Oct; 43(10):701-708. PubMed ID: 32694298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
    De Bari B; Jumeau R; Bouchaab H; Vallet V; Matzinger O; Troussier I; Mirimanoff RO; Wagner AD; Hanhloser D; Bourhis J; Ozsahin EM
    Acta Oncol; 2016 Jun; 55(6):767-73. PubMed ID: 27034083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinoma--clinical outcomes in a large National Cancer Institute-designated integrated cancer centre network.
    DeFoe SG; Beriwal S; Jones H; Rakfal S; Heron DE; Kabolizadeh P; Smith RP; Lalonde R
    Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):424-31. PubMed ID: 22075444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy.
    Hallemeier CL; You YN; Larson DW; Dozois EJ; Nelson H; Klein KA; Miller RC; Haddock MG
    Dis Colon Rectum; 2014 Apr; 57(4):442-8. PubMed ID: 24608300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
    Ajani JA; Winter KA; Gunderson LL; Pedersen J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett C
    JAMA; 2008 Apr; 299(16):1914-21. PubMed ID: 18430910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of advancing age on treatment and outcomes in anal cancer.
    Foo M; Link E; Leong T; Chu J; Lee MT; Chander S; Tran PK; Tomaszewski JM; Michael M; Heriot A; Ngan SY
    Acta Oncol; 2014 Jul; 53(7):909-16. PubMed ID: 24456502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Rectal squamous cell carcinoma treatment: Retrospective experience in two French university hospitals, review and proposals].
    Schernberg A; Servagi-Vernat S; Loganadane G; Touboul E; Bosset JF; Huguet F
    Cancer Radiother; 2016 Dec; 20(8):824-829. PubMed ID: 27789176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced anal squamous cell carcinoma -- radiotherapy or surgery?
    Smigielski J; Rychter A; Fijuth J; Brocki M
    Chirurgia (Bucur); 2012; 107(5):626-30. PubMed ID: 23116837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.